Cheap Generic Ozempic Set To Enter India As Patent Expiry Triggers Weight-Loss Drug Boom
Business
- 20 days ago
Generic semaglutide in India post-patent expiry could lower costs and expand obesity care through hospitals, clinics and telehealth platforms, altering the GLP-1 market.